A detailed history of Fulton Bank, N.A. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fulton Bank, N.A. holds 3,305 shares of CRL stock, worth $621,207. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,305
Previous 3,148 4.99%
Holding current value
$621,207
Previous $852,000 19.95%
% of portfolio
0.06%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$206.39 - $268.73 $32,403 - $42,190
157 Added 4.99%
3,305 $682,000
Q1 2024

Apr 10, 2024

BUY
$203.52 - $273.43 $8,140 - $10,937
40 Added 1.29%
3,148 $852,000
Q4 2023

Jan 04, 2024

BUY
$164.52 - $238.84 $31,752 - $46,096
193 Added 6.62%
3,108 $734,000
Q3 2023

Oct 04, 2023

BUY
$194.44 - $217.61 $64,748 - $72,464
333 Added 12.9%
2,915 $571,000
Q2 2023

Jul 06, 2023

BUY
$183.71 - $210.25 $23,331 - $26,701
127 Added 5.17%
2,582 $542,000
Q1 2023

Apr 06, 2023

BUY
$191.89 - $259.92 $74,261 - $100,589
387 Added 18.71%
2,455 $495,000
Q4 2022

Jan 05, 2023

SELL
$197.11 - $250.07 $92,641 - $117,532
-470 Reduced 18.52%
2,068 $450,000
Q3 2022

Oct 04, 2022

BUY
$182.44 - $250.54 $45,062 - $61,883
247 Added 10.78%
2,538 $500,000
Q2 2022

Jul 07, 2022

BUY
$204.13 - $302.4 $69,608 - $103,118
341 Added 17.49%
2,291 $490,000
Q1 2022

Apr 05, 2022

BUY
$255.51 - $362.11 $50,335 - $71,335
197 Added 11.24%
1,950 $554,000
Q4 2021

Jan 05, 2022

BUY
$351.38 - $448.68 $100,143 - $127,873
285 Added 19.41%
1,753 $660,000
Q3 2021

Oct 05, 2021

BUY
$372.64 - $458.3 $40,990 - $50,413
110 Added 8.1%
1,468 $606,000
Q2 2021

Jul 06, 2021

SELL
$294.17 - $371.65 $2,647 - $3,344
-9 Reduced 0.66%
1,358 $502,000
Q1 2021

Apr 05, 2021

BUY
$249.67 - $299.48 $88,133 - $105,716
353 Added 34.81%
1,367 $396,000
Q4 2020

Jan 07, 2021

BUY
$222.0 - $252.62 $225,108 - $256,156
1,014 New
1,014 $253,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fulton Bank, N.A. Portfolio

Follow Fulton Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.